GEO-MVA Archives - Vista Partners LLC | HomeVista Partners LLC

Atlanta Joins the Ebola Watchlist: How One Airport and One Biotech Are Keeping Calm and Carrying On -( $DAL $GOVX $XBI )

by John F. Heerdink, Jr. May 24, 2026 208Views 0Likes

The United States is quietly tightening its Ebola defenses, and this time Atlanta’s massive air hub and a small vaccine developer based in Atlanta named GeoVax Labs (NASDAQ: GOVX) are sharing the spotlight in a story that is more about preparedness than…

GeoVax Joins the “Post‑Prasad” Party With a Well‑Timed Signal to Buyers and Bureaucrats -( $GOVX $INO $TNXP $VRTX $IBB $XBI )

by John F. Heerdink, Jr. March 11, 2026 361Views 0Likes

The timing could hardly be better: as controversial FDA leader, Vinay Prasad, exits FDA’s CBER and sentiment tilts back toward innovation, GeoVax Labs (NASDAQ: GOVX) has launched formal outreach around future procurement of its GEO‑MVA mpox/smallpox vaccine. The company is effectively telling…

GeoVax Tries on Its 2026 “Breakout Year” Jacket — And It Might Just Fit -( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. February 17, 2026 522Views 0Likes

GeoVax Labs (NASDAQ: GOVX) is stepping into 2026 talking like an inflection‑year story—and, unusually for biotech, it has the clinical, regulatory and manufacturing pieces to at least justify the wardrobe change. While capital remains tight, the company is pairing late‑stage Mpox vaccine…

Tag: GEO-MVA

Atlanta Joins the Ebola Watchlist: How One Airport and One Biotech Are Keeping Calm and Carrying On -( $DAL $GOVX $XBI )

GeoVax Joins the “Post‑Prasad” Party With a Well‑Timed Signal to Buyers and Bureaucrats -( $GOVX $INO $TNXP $VRTX $IBB $XBI )

GeoVax Tries on Its 2026 “Breakout Year” Jacket — And It Might Just Fit -( $GOVX $IBB $XBI )

Your Guide To Staying Informed In The Markets